Zobrazeno 1 - 10
of 4 474
pro vyhledávání: '"Ishii KJ"'
Bisphenol A triggers activation of ocular immune system and aggravates allergic airway inflammation.
Autor:
Ueda T; Department of Immunology, Hyogo Medical University, School of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan; Department of Otorhinolaryngology-Head and Neck Surgery, Hyogo Medical University School of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan., Adachi T; Department of Immunology, Hyogo Medical University, School of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan., Hayashi T; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo 108-8639, Japan., Yasuda K; Department of Immunology, Hyogo Medical University, School of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan., Matsushita K; Department of Immunology, Hyogo Medical University, School of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan., Koike E; Health and Environmental Risk Division, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba 305-8506, Japan., Yanagisawa R; Health and Environmental Risk Division, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba 305-8506, Japan., Nagatake T; Laboratory of Functional Anatomy, Department of Life Sciences, School of Agriculture, Meiji University, 1-1-1 Higashi-Mita, Tama, Kawasaki 214-8571, Japan; Laboratory of Vaccine Materials and Laboratory of Gut Environmental System, Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition, 7-6-8 Asagi-Saito, Ibaraki 567-0085, Japan., Kunisawa J; Laboratory of Vaccine Materials and Laboratory of Gut Environmental System, Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition, 7-6-8 Asagi-Saito, Ibaraki 567-0085, Japan., Ishii KJ; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo 108-8639, Japan., Tsuzuki K; Department of Otorhinolaryngology-Head and Neck Surgery, Hyogo Medical University School of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan., Kuroda E; Department of Immunology, Hyogo Medical University, School of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan. Electronic address: kuroetu@hyo-med.ac.jp.
Publikováno v:
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2024 Nov; Vol. 268, pp. 110370. Date of Electronic Publication: 2024 Sep 28.
Autor:
Iijima N; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Saito Asagi, Ibaraki, Osaka, Japan; Laboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Saito Asagi, Ibaraki, Osaka, Japan. Electronic address: norifumi.iijima@aya.yale.edu., Yamaguchi M; Bioinformatics Research Unit, Osaka University Graduate School of Dentistry, Suita Osaka, Japan; Bioinformatics Center, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; Department of Microbiology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan; Center for Infectious Diseases Education and Research, Osaka University, Suita, Osaka, Japan., Hayashi T; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Saito Asagi, Ibaraki, Osaka, Japan; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Rui Y; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Saito Asagi, Ibaraki, Osaka, Japan., Ohira Y; Central Research Laboratories, Zeria Pharmaceutical Co, Ltd, Kumagaya-shi, Saitama, Japan., Miyamoto Y; Laboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Saito Asagi, Ibaraki, Osaka, Japan., Niino M; Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Sapporo, Hokkaido, Japan., Okuno T; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Suzuki O; Laboratory of Animal Models for Human Diseases, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Asagi Saito, Ibaraki, Osaka, Japan., Oka M; Laboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Saito Asagi, Ibaraki, Osaka, Japan., Ishii KJ; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Saito Asagi, Ibaraki, Osaka, Japan; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan; WPI Immunology Frontier Research Center (IFReC), Osaka Univerisity, Suita, Osaka, Japan. Electronic address: kenishii@ims.u-tokyo.ac.jp.
Publikováno v:
Journal of autoimmunity [J Autoimmun] 2024 Oct 11; Vol. 149, pp. 103319. Date of Electronic Publication: 2024 Oct 11.
Autor:
Iijima N; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Osaka, Ibaraki, Japan.; Laboratory of Nuclear Transport Dynamics, Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Osaka, Ibaraki, Japan., Hayashi T; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Osaka, Ibaraki, Japan.; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Minato-ku, Japan., Niino M; Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Sapporo, Hokkaido, Japan., Miyamoto Y; Laboratory of Nuclear Transport Dynamics, Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Osaka, Ibaraki, Japan., Oka M; Laboratory of Nuclear Transport Dynamics, Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Osaka, Ibaraki, Japan., Ishii KJ; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Osaka, Ibaraki, Japan.; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Minato-ku, Japan.; WPI Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Suita, Japan.
Publikováno v:
European journal of immunology [Eur J Immunol] 2024 Oct; Vol. 54 (10), pp. e2350957. Date of Electronic Publication: 2024 Jul 18.
Autor:
Yaku H; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Takahashi K; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Division of Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: takaken@kuhp.kyoto-u.ac.jp., Okada H; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Gastroenterology and Hepatology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan., Kobiyama K; Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center, The University of Tokyo, Tokyo, Japan., Shiokawa M; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Uza N; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kobe University, Kobe, Japan., Kodama Y; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kobe University, Kobe, Japan., Ishii KJ; Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center, The University of Tokyo, Tokyo, Japan., Seno H; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Dec 10; Vol. 737, pp. 150534. Date of Electronic Publication: 2024 Aug 08.
Autor:
Alshaweesh J; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.; International Vaccine Design Center, IMSUT, The University of Tokyo, Tokyo 108-8639, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan., Dash R; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.; Department of Computational Biology and Medical Science (CBMS), Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan., Lee MSJ; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.; International Vaccine Design Center, IMSUT, The University of Tokyo, Tokyo 108-8639, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan., Kahyaoglu P; Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan.; Department of Paediatrics, Hacettepe University School of Medicine, Ankara 06100, Turkey., Erci E; Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan.; Department of Paediatrics, Hacettepe University School of Medicine, Ankara 06100, Turkey., Xu M; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.; Department of Computational Biology and Medical Science (CBMS), Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan., Matsuo-Dapaah J; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.; Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan., Del Rosario Zorrilla C; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.; Department of Computational Biology and Medical Science (CBMS), Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan., Aykac K; Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan.; Department of Paediatrics, Hacettepe University School of Medicine, Ankara 06100, Turkey.; Ministry of Health University, Ankara Education and Research Hospital, Paediatric Infectious Diseases Unit, Ankara 06230, Turkey., Ekemen S; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan., Kobiyama K; International Vaccine Design Center, IMSUT, The University of Tokyo, Tokyo 108-8639, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan.; Division of Vaccine Science, Department of Microbiology and Immunology, IMSUT, The University of Tokyo, Tokyo 108-8639, Japan., Ishii KJ; International Vaccine Design Center, IMSUT, The University of Tokyo, Tokyo 108-8639, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan.; Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan.; Division of Vaccine Science, Department of Microbiology and Immunology, IMSUT, The University of Tokyo, Tokyo 108-8639, Japan., Coban C; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.; International Vaccine Design Center, IMSUT, The University of Tokyo, Tokyo 108-8639, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan.; Department of Computational Biology and Medical Science (CBMS), Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan.; Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan.; Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan.
Publikováno v:
International immunology [Int Immunol] 2024 Aug 13; Vol. 36 (9), pp. 451-464.
Autor:
Lee MSJ; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.; International Vaccine Design Center, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan., Matsuo-Dapaah J; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan., Del Rosario Zorrilla C; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan., Omatsu Y; Laboratory of Stem Cell Biology and Developmental Immunology, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.; Laboratory of Stem Cell Biology and Developmental Immunology, WPI Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan., Nagasawa T; Laboratory of Stem Cell Biology and Developmental Immunology, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.; Laboratory of Stem Cell Biology and Developmental Immunology, WPI Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan., Uemura S; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan., Iwama A; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.; Laboratory of Cellular and Molecular Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan., Ishii KJ; International Vaccine Design Center, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan.; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.; WPI Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan., Coban C; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.; International Vaccine Design Center, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo 108-8639, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan.; WPI Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan.
Publikováno v:
International immunology [Int Immunol] 2024 Jun 08; Vol. 36 (7), pp. 339-352.
Autor:
Sasaki I; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Japan. Electronic address: izumisas@wakayama-med.ac.jp., Fukuda-Ohta Y; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Japan; Laboratory for Protein Conformation Diseases, RIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan., Nakai C; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Wakaki-Nishiyama N; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Okamoto C; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Okuzaki D; Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan., Morita S; First Department of Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Kaji S; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Furuta Y; Department of Thoracic and Cardiovascular Surgery, Wakayama Medical University, Wakayama 641-8509, Japan., Hemmi H; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Japan; Laboratory of Immunology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime 794-8555, Japan., Kato T; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Yamamoto A; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Tosuji E; Department of Dermatology, Wakayama Medical University, Wakayama 641-8509, Japan., Saitoh SI; Department of Intractable Disorders, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Tanaka T; Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Science, Yokohama, Kanagawa 230-0045, Japan., Hoshino K; Department of Immunology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan., Fukuda S; Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997-0052, Japan; Gut Environmental Design Group, Kanagawa Institute of Industrial Science and Technology, Kawasaki, Kanagawa 210-0821, Japan; Transborder Medical Research Center, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan; Laboratory for Regenerative Microbiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan., Miyake K; Division of Innate Immunity, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan., Kuroda E; Department of Immunology, School of Medicine, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan., Ishii KJ; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan., Iwawaki T; Division of Cell Medicine, Department of Life Science, Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan., Furukawa K; Department of Biomedical Sciences, Chubu University College of Life and Health Sciences, Kasugai, Aichi 487-8501, Japan., Kaisho T; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Japan. Electronic address: tkaisho@wakayama-med.ac.jp.
Publikováno v:
Cell reports [Cell Rep] 2024 Apr 23; Vol. 43 (4), pp. 113981. Date of Electronic Publication: 2024 Mar 24.
Autor:
Palacpac NMQ; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan. Electronic address: nirian@biken.osaka-u.ac.jp., Ishii KJ; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka 567-0085, Japan; Laboratory of Vaccine Science, Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. Electronic address: kenishii@ims.u-tokyo.ac.jp., Arisue N; Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan. Electronic address: arisue.nobuko@twmu.ac.jp., Tougan T; Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan. Electronic address: ttougan@biken.osaka-u.ac.jp., Horii T; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan. Electronic address: horii@biken.osaka-u.ac.jp.
Publikováno v:
Parasitology international [Parasitol Int] 2024 Apr; Vol. 99, pp. 102845. Date of Electronic Publication: 2023 Dec 13.
Autor:
Temizoz B; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), Tokyo, Japan., Shibahara T; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan., Hioki K; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Hayashi T; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), Tokyo, Japan., Kobiyama K; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), Tokyo, Japan., Lee MSJ; International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), Tokyo, Japan.; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan., Surucu N; Department of Biological Sciences, Middle East Technical University (METU), Ankara, Türkiye., Sag E; Department of Pediatric Rheumatology, Hacettepe University, Ankara, Türkiye., Kumanogoh A; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.; Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan., Yamamoto M; Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan.; Department of Immunoparasitology, Division of Infectious Disease, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan., Gursel M; MG Laboratory on Vaccines and Immunotherapeutics, Basic and Translational Research Program, Izmir Biomedicine and Genome Center, Izmir, Türkiye., Ozen S; Department of Pediatric Rheumatology, Hacettepe University, Ankara, Türkiye., Kuroda E; Department of Immunology, School of Medicine, Hyogo Medical University, Hyogo, Japan., Coban C; International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), Tokyo, Japan.; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan.; Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan., Ishii KJ; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan.; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), Tokyo, Japan.; Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Mar 12; Vol. 15, pp. 1353336. Date of Electronic Publication: 2024 Mar 12 (Print Publication: 2024).
Autor:
Guo Z; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan., Murakami M; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.; Skin Care Institute, Mandom Corporation, Osaka, Japan., Saito K; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.; Advanced Technology Institute, Mandom Corporation, Osaka, Japan.; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan., Kato H; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan., Toriyama M; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.; Graduate School of Science and Technology, Nara Institute of Science and Technology, Nara, Japan., Tominaga M; Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Okazaki, Japan.; National Institute for Physiological Sciences, National Institutes of Natural Sciences, Okazaki, Japan.; Department of Physiological Sciences, Sokendai (The Graduate University for Advanced Studies), Okazaki, Japan., Ishii KJ; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.; Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Fujita F; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.; Advanced Technology Institute, Mandom Corporation, Osaka, Japan.; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Publikováno v:
Experimental dermatology [Exp Dermatol] 2024 Mar; Vol. 33 (3), pp. e15021.